Primary content

Related to 'Childhood cancers'

Lung cancers in children under the age of 15 are very uncommon, and detection of these cancers can be difficult due to the rarity of the disease and symptoms that are generally non-specific.

Children with cancer in NSW will receive more personalised and effective treatment options through new investment in cutting-edge technologies at the Children’s Cancer Institute.

The Toronto Guidelines provide a highly functional framework that can be used to assign cancer stage at diagnosis using data routinely available in medical records for most childhood cancers.

Stage at diagnosis was applied to population data on children with blood cancers, showing variable survival by stage for acute lymphoblastic leukemia and non-Hodgkin lymphoma, but no difference in survival by stage for acute myeloid leukemia. Almost all children with Hodgkin lymphoma survived five years.

Almost three quarters of children diagnosed with one of twelve solid malignancies had localised or regional disease at diagnosis, and differences in 5-year survival by stage were greatest for osteosarcoma, neuroblastoma, and rhabdomyosarcoma.

Improving the future for children with cancer in NSW will be a key focus of new funding from the Cancer Institute NSW, announced today by Minister for Health and Medical Research, Brad Hazzard.